Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial

出版年份 2021 全文链接

标题

作者

关键词

出版物

Volume 27, Issue 16, Pages 4491-4499

出版商

American Association for Cancer Research (AACR)

发表日期

2021-06-03

DOI

10.1158/1078-0432.ccr-21-0611

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discuss science. Find collaborators. Network.

Join a conversation